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The selection of antibiotic resistance by cotrimoxazole prophylaxis was evaluated, and we characterized the mechanism of
cotrimoxazole resistance in Streptococcus mutans and Streptococcus sobrinus. In vitro susceptibility to six antibiotics was evaluated
on 64 mutans streptococci group (MSG) isolates from a cotrimoxazole prophylaxis group and compared to 84 MSG isolates from
a nonprophylaxis group. The folA and folP genes were sequenced and compared with reference sequences at NCBI. Only resistance
to cotrimoxazole was signiﬁcantly higher in the prophylaxis group (54.7% versus 15.5%, OR = 6.59, 95% CI: 2.89–15.3, P<0.05).
Resistance to amoxicillin, ceftriaxone, chloramphenicol, erythromycin, and tetracycline was 1.4%, 25.5%, 6.2%, 6.5%, and 29.6%
of the isolates, respectively. Considerable polymorphisms were found in the folP gene in S. mutans, but this could not be linked
to sulfonamide drug resistance. No variation was seen in folP or folA genes of S. sobrinus. Genetic transfer of folate pathway genes
seems unlikely in these isolates.
1.Introduction
Themutansstreptococcigroup(MSG)belongtotheviridans
g r o u ps t r e p t o c o c c i( V G S )a n df o r ma ni m p o r t a n tp a r to f
the normal oral ﬂora [1, 2]. Although the VGS are generally
nonpathogenic, they have attracted attention due to their
ability to act as reservoirs for antibiotic resistance genes and
to transfer these troublesome traits to classically pathogenic
bacteria including Streptococcus pneumoniae and Streptococ-
cus pyogenes [3]. While a number of recent studies [4, 5]h a v e
investigated the susceptibility patterns of the VGS to various
antimicrobial agents, only a few studies [6]h a v er e p o r t e d
antimicrobial sensitivity of VGS from sub-Saharan Africa
even though antibiotic abuse is widespread in the region [7].
More speciﬁcally, it has been observed that cotrimoxazole
(SXT) prophylaxis selects for resistance in infectious strep-
tococci [8, 9]. However, information on the eﬀects of SXT
prophylaxis on commensal bacteria which are not the drug
targets is still scarce, particularly in sub-Saharan Africa bear-
ing a heavy burden of human immunodeﬁciency virus infec-
tion/acquired immunodeﬁciency syndrome (HIV/AIDS)
and where a large proportion of the patients routinely take
SXT as prophylaxis against Pneumocystis jiroveci pneumonia.
The MSG includes seven species of which Streptococcus
mutans and Streptococcus sobrinus infect human populations
[10]. As the principal causative agents of dental caries (tooth
decay) and related odontogenic pyogenic infections, the
MSG is commonly referred to as cariogenic bacteria [11].
They are also implicated in causing extra-oral infections,
particularly subacute bacterial endocarditis in patients with
defective or prosthetic valves [12, 13]. Assessment of antibi-
otic susceptibility and characterisation of the mechanisms
of the resistance of the MSG is increasingly important not
only because these bacteria are the leading cause of dental
and serious extra-oral infections but also because they can
carry and transfer antibiotic resistance genes to typically2 International Journal of Microbiology
pathogenic microbes [14]. Additionally, to our knowledge
the mechanism of Streptococcus mutans and Streptococcus
sobrinus resistance to cotrimoxazole has not been charac-
terised.
Here, we have evaluated the selection of antibiotic resis-
tance by SXT prophylaxis and characterised the mechanism
of Streptococcus mutans and Streptococcus sobrinus resistance
to SXT. The bacteria were isolated from saliva of patients
attending Mulago Hospital Dental Clinic and The AIDS
Support Organization (TASO) clinic in Kampala, Uganda.
2. Methods
2.1. Study Areas. This study was conducted in TASO Clinic
and Mulago Hospital Dental Clinic located in Kampala,
Uganda. TASO is a nongovernmental HIV/AIDS care clinic
that attends to about 100 patients daily who regularly take
SXT as prophylaxis. Mulago Hospital is the national referral
hospital. It has a dental clinic which daily oﬀers treatment to
about50outpatientswhoseHIVsero-statusisundetermined
and is not taking SXT as prophylaxis.
2.2. Study Design and Subjects. This was a cross-sectional
study of patients (n = 204) from TASO Clinic who were
routinely taking SXT as prophylaxis (prophylaxis group) and
another group of patients (n = 171) from Mulago Dental
clinic that were not taking SXT as prophylaxis (nonpro-
phylaxis group). To increase chances of isolating MSG, the
patients were selected on condition that they had at least one
tooth with dental caries conﬁrmed by clinical examination.
Demographic data and information on use of antibiotics
in the previous three months were obtained from patients’
interview and medical records.
2.3. Ethical Considerations. Permission to carry out this
study was obtained from Makerere University School of
Medicine Research and Ethics Committee and the Uganda
National Council of Science and Technology. Written con-
sent was sought and obtained from each study subject
consistent with the Helsinki Declaration relating to the
conduct of research on human subjects [15].
2.4. Microbiological Procedures and Antibiotic Resistance. All
the selected patients (n = 375) donated saliva specimens for
the study. At least 1h following the patient’s meal, 2mL of
whole saliva was collected in a sterile falcon tube (Sarstedt,
Austria),andwithin1hofbeingcollected,thespecimenwere
transported to the Department of Biochemistry, Makerere
University College of Health Sciences for analysis. Each spec-
imen was diluted 1:100 in physiological saline (Chemtrec,
USA)and100μLofthedilutedsamplewasculturedonplates
containing modiﬁed HLR-S medium [16] for selective isola-
tionofMSG.Theplateswereincubatedat37◦Cfor48hinan
atmosphere of 5% carbon dioxide. One presumptive colony
of MSG was picked and streaked on chocolate agar plates
(BioM´ erieux, France), supplemented with 5% sheep blood
and polyvitex (BioM´ erieux, France). The colonies from
chocolateagarwereidentiﬁedbymorphology,gramstaining,
haemolysis on blood agar medium (BioM´ erieux, France),
catalase test, and susceptibility to optochin [2]. Subsequent
diﬀerentiation of the bacteria was done by biochemical tests
[2, 17] and conﬁrmed by polymerase chain reaction (PCR)
genotyping of the glycosyl transferase (gtf)g e n e[ 10]. After
conﬁrmation of the bacterial species by PCR, susceptibility
to amoxicillin and cotrimoxazole was evaluated using E-
test (AB Biodisk, Sweden) whereas susceptibility to cef-
triaxone, erythromycin, tetracycline, and chloramphenicol
was assessed by the Kirby Bauer disc diﬀusion method
(BioM´ erieux, France) [18]. The break points criteria for
streptococcal species other than Streptococcus pneumoniae
established by the CLSI [18] were used for all the antibiotics
studied except for cotrimoxazole in which the break points
established by the Swedish Reference Group for Antibiotics
[19]w e r ea d o p t e d .
2.5. Deoxyribonucleic Acid (DNA) Extraction. Isolates of
MSG were incubated at 37◦C for 12h on chocolate agar. Bac-
teria from one colony were resuspended in Trypticase Soy
broth (BioM´ erieux, France) and incubated at 37◦Cf o r2 4h
in an atmosphere of 5% carbon dioxide. Bacterial DNA
from the cultured streptococci was then extracted using a
modiﬁed protocol of the Wizard Genomic DNA Puriﬁcation
Kit (Promega, USA).
2.6. Polymerase Chain Reaction for Species Identiﬁcation.
Sequences of the primers used in PCR conﬁrmation of bac-
terial species were as previously described [10]. In this
procedure, a DNA fragment (517 bp) of the gtfB gene of
Streptococcus mutans or a longer fragment (712bp) of the
gtfI geneof Streptococcussobrinuswasampliﬁed.Brieﬂy,each
PCR mixture of 20μLc o n t a i n e dD r e a m T a qg r e e nb u ﬀer
(Fermentas, Lithuania), 100μM each of dATP, dTTP, dGTP,
anddCTP,0.5μMoligonucleotideprimers(bothGTFB-F,-R
and GTFI-F, -R), 1.25U of DreamTaq polymerase (Fermen-
tas, Lithuania), and 0.5 to 1nanogram of template DNA.
The PCR conditions comprised 30 cycles of denaturation
at 95◦C for 30s, annealing at 59◦Cf o r3 0s ,a n de x t e n s i o n
at 72◦Cf o r1m i n .T h ea m p l i ﬁ e dp r o d u c t sw e r es e p a r a t e db y
electrophoresis in 0.8% agarose gels (Sigma, Belgium) and
stained with ethidium bromide (BDH, UK).
2.7. Statistical Analysis. The data were analyzed using the
Statistical Package for Social Sciences Inc. (version 12.0 for
Windows, Chicago, IL, USA). Frequency distribution was
used to describe the material. The dependent variable (SXT
prophylaxisuse)wascategorizedas1=yesand2 =no.Binary
logistic regression analyses were used to estimate the mag-
nitude of the risk of bacteria in developing drug resistance
in the prophylaxis and nonprophylaxis groups. The 95%
conﬁdence intervals were generated around all odds ratios
(OR) to determine the signiﬁcance of predictor variables. A
P value of <0.05 was considered statistically signiﬁcant.
2.8. Sequence Analysis. DNA from a number of isolates was
sequenced using the BigDye Terminator labelled cycle se-
quencing kit (Applied Biosystems) and an ABI prism 310International Journal of Microbiology 3
Table 1: Primers used.
DHFRS-F TTTCTTAATTTCTGATAGAATG
DHFRS-R1 GCCGTAAACACCCCAAAAAT
DHFRM-F1 TGGTTGGGTAAAATGGGAAC
DHFRM-R GCATATCTTAAGCCAATC
Operon 11 Reverse AGAGCATTCAGCAAAAGTCC
Operon 24 Forward TGTCTGTCATCTTCTGCCC
Operon 24 Reverse CCTATCACAACCCTTCGTCC
MdhpsSph GATCGATCGCATGCACATCATAACTAGGGAGCAAGC
MdhpsBam GATGGATCGGATCCAAAATAATCTTATCCATAACACCCTCA
Dhpssrevnew GCGGGAAATACCAAAGAGGAC
Gtchsfw GCCTTGGAAGAAGCCTTAGAC
Gtpchfw2 ACTTTGATTAAGGAGCACTAG
Gtpchfw3 TATGTGTATGACTATGCGAGG
Downei dhps rev1 AAAAGTATTTTATCCATATTC
Downei dhps rev2 CCCTTTAAAAGTATTTTATCCAT
GeneticAnalyzer(AppliedBiosystems)inUppsalaUniversity
Sweden.PrimersusedforDNAampliﬁcationandsequencing
reactions are listed in Table 1. The results of the folA and
folP gene sequence analysis were compared with database
sequences of S. mutans UA 159 [20] and NN2025 [21] using
the BLAST programme at NCBI. Additionally, the folP gene
of isolate 797 was compared to a number of organisms using
the multiple sequence alignment program clustalW at the
European Bioinformatics Institute database.
2.9. Cloning of the folP Gene from Strain 797. Isolate 797 with
most point mutations was further characterised. The folP
gene of strain 797 was ampliﬁed using primers MdhpsSph
and MdhpsBam (Table 1) where recognition sequences for
the restriction enzymes SphIa n dBamHI were engineered
into the forward and reverse ampliﬁcation primers, respec-
tively. The resulting PCR product was digested with these
two enzymes together with the plasmid vector pUC19. After
ligation of PCR product and vector using the Rapid Ligation
Kit(Fermentas,Lithuania),theresultingplasmidwasusedto
transform competent cells of E. coli DH5α.A f t e rv e r i ﬁ c a t i o n
of the plasmid construction, it was introduced into the E. coli
knock-out strain C600ΔfolP [22].
2.10. Cloning and Sequencing of the folP Gene from Strepto-
coccus sobrinus. No full genome sequence of S. sobrinus is
available, but the sequence of the closely related species S.
downei was recently added to the databases. Thus, primers
were designed to match the S. downei sequence as shown
in Table 1. PCR was performed with an annealing tem-
perature of 45◦C; otherwise, the PCR conditions were as
described previously. Sequencing reactions and analysis were
as described previously.
2.11. Selection of Trimethoprim Resistant Variants of Strep-
tococcus mutans Strain 797. When cultivated in the lab, S.
mutans strain 797 showed stable resistance to sulfamethoxa-
zole but susceptibility to trimethoprim (tp). The strain was
cultivated in Isosensitest Broth (ISB) (Oxoid, UK) with a
low concentration (2μg/mL) of tp, where growth was very
weak. From this culture, the bacteria were inoculated into
tubes containing ISB with 5μg/mL of tp and from this
culture subsequently reinoculated into ISB with 10μg/mL
of tp. From the latter two cultures, bacteria were streaked
onto Isosensitest Agar (ISA) plates (Oxoid,UK) containing
10μg/mL of tp. Bacteria from both tubes grew on the selec-
tive plates and were called 797 (5) and 797 (10), respectively.
2.12. Competition Experiments. Bacteria strains 797(10) and
797 were inoculated in the 2mL of Brain Heart Infusion
(BHI) (BioM´ erieux, France) in the following proportions:
Tube 1, 100μL 797(10); Tube 2, 10μL 797(10) + 90μL 797;
Tube 3, 50μL 797(10) + 50μL 797; Tube 4, 90μL 797(10) +
10μL 797; and Tube 5, 100μL 797. Additionally, 100μLo f
797(10) and 797 diluted 10 times was spread on ISA plates
(Oxoid,UK) in order to get individual colonies, which was
counted to identify the initial proportions.
The ﬁve cultures were then incubated overnight at 37◦C
in a 5% CO2 atmosphere. At a 6 hourly interval: 0, 6, 12,
18, and 24 hours, 10μL of bacteria was removed from each
test tube and diluted 100 times in BHI broth (BioM´ erieux,
France). One hundred μL of the dilutions was then spread
on ISA plates (Oxoid, UK) and incubated overnight at
37 degrees in a 5% CO2 atmosphere. The following day,
individual colonies were picked and inoculated on ISA plates
(Oxoid,UK) with and without trimethoprim 10μg/mL. This
experiment was done three times and the averages of the
proportion of resistant to susceptible colonies grown on the
ISA plates were counted and plotted against time.
3. Results
3.1. Antibiotic Resistance Patterns in the Prophylaxis Group
(n = 204). Based on culture and gtf genotyping, 31.4%(n =
64) of the patients’ specimens had MSG strains. Thirty six
(56%) of the strains were S. mutans and 28 (44%) were4 International Journal of Microbiology
Table 2: Comparison of the diﬀerent antibiotic susceptibilities of the nonprophylaxis and prophylaxis groups∗.
Antibiotic
STX prophylaxis use OR 95% CI
No
n (%)
Yes
n (%)
Cotrimoxazole S 71 (84.5) 29 (45.3) 6.59 2.89–15.37
R 13 (15.5) 35 (54.7)
Amoxicillin
S 61 (72.6) 41 (64.1) 1.49 0.02–118.67
R 1 (1.2) 1 (1.6)
I 22 (26.2) 22 (34.4)
Tetracycline
S 38 (45.2) 38 (59.4) 0.50 0.22–1.15
R 30 (35.7) 15 (23.4)
I 16 (19.0) 11 (17.2)
Erythromycin
S 74 (88.1) 49 (76.6) 3.02 0.63–19.37
R 3 (3.6) 6 (9.4)
I 7 (8.3) 9 (14.1)
Chloramphenicol
S 72 (85.7) 54 (84.4) 1.07 0.2–5.21
R 5(6) 4 (6.3)
I 7 (8.3) 6 (9.4)
Ceftriaxone
S 46 (54.8) 50 (78.1) 0.41 0.17–0.96
R 27 (32.1) 12 (18.8)
I 11 (13.1) 2 (3.1)
S: susceptible; R: resistant; ∗Intermediate resistance was not used in calculating OR.
Table 3: The frequency distribution of coresistance in the nonprophylaxis and the prophylaxis groups.
Number of antibiotics to which isolates were resistant Nonprophylaxis group n
(%) Prophylaxis group n (%)
0 32 (37.2) 14 (21.9)
1 23 (26.7) 20 (31.3)
2 19 (22.1) 18 (28.1)
More than 2 12 (14.0) 12 (18.7)
Total 84 (100) 64 (100)
S. sobrinus. There were no statistically signiﬁcant diﬀerences
in the resistance pattern of the various antibiotics between S.
sobrinusand S. mutans(P>0.05); thusthedatawerepooled.
Cotrimoxazole showed the highest resistance (54.7%), while
amoxicillin had the lowest resistance (1.6%, Table 2). The
risk of developing resistance to SXT in the prophylaxis group
was 6.59 times higher than that in the nonprophylaxis group
(P<0.05, Table 2). For other antibiotics, there were no
signiﬁcant diﬀerences in resistance rates between the two
study groups. The risk of developing multidrug resistance
(MDR), that is, resistance to more than 2 drugs in the
prophylaxis group, was 1.42 times higher than that in the
nonprophylaxis group. However, the diﬀerence was not
statistically signiﬁcant (95% CI: 0.55–3.71, Table 3). Based
ontheindividual components ofSXT(sulfamethoxazoleand
trimethoprim), most (95%) of the isolates in the prophylaxis
group showed resistance to sulfamethoxazole, while 61% of
resistance was towards trimethoprim.
3.2. Antibiotic Resistance Patterns in the Nonprophylaxis
Group (n = 171). In the nonprophylaxis group, 51% (n =
87) of the patients had positive growth of MSG bacteria.
According to gtf genotyping, 37 (43%) of the strains were
Streptococcus mutans a n d4 7( 5 4 % )w e r eStreptococcus sobri-
nus while 3 (3.4%) of the specimens contained both species.
The most prevalent resistance was associated with tetra-
cycline (35.7%), while the least resistance was found with
erythromycin (3.6%, Table 2). Resistance to cotrimoxazole
in the nonprophylaxis group was 15.5%. Coresistance of the
isolates to diﬀerent antibiotics is shown in Table 3.O v e r a l l ,
MDRwasobservedin14%ofthenonprophylaxisspecimens.
3.3. Determination of folA Sequences in Susceptible and Resis-
tant Isolates. Sequence analysis of the folA gene from S.
mutans as compared to the database sequences UA159 and
NN2025 revealed no point mutations irrespective of the
susceptibility status of the strain. One isolate, 797, was
chosen for more detailed analysis. It was originally isolated
as a trimethoprim (tp) resistant strain but lost the resis-
tance upon subculturing in the lab. Further application of
trimethoprim selective pressure on the strain in the lab
led to its rapid development of resistance to trimethoprim.International Journal of Microbiology 5
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Figure 1: Plot of resistant bacteria after competition between sus-
ceptible 797 and resistant 797 (10).
When the two lab isolates 797 (5) and 797 (10) were derived
and selected on 5μg/mL and 10μg/mL of trimethoprim,
respectively, the full nucleotide sequence for the thyA,a
gene coding for a putative transporter, and folA genes were
determined including the upstream sequence of thyA,b u t
no single nucleotide change was detected in this region.
Based on the lab-derived tp resistant strains in competition
experiments with the original 797, the tp susceptible isolate
797 was found to be more ﬁt than the tp resistant 797(10)
(Figure 1). The tp susceptible isolate outgrew the resistant
strain over a 24-hour period even when added in a minority
proportion.
3.4.DeterminationoffolPSequences. Sequenceanalysisofthe
folP gene for 797 revealed four point mutations in positions
at A46 V, E 80K, Q122 H, and S146G when compared to the
database sequence of strain NN 2025. However, in compar-
ison with the other published sequence from UA 159, only
positionS146Gdiﬀeredin797.FurthercomparisonofDHPS
from isolate 797 with DHPS from other sulfonamide resis-
tant organisms (Figure 2) showed that the diﬀerences occur
outside of previously characterised mutation determining
positions. The folP gene was much more polymorphic than
the folA gene. Sequence determinations from a number
of other isolates showed ten diﬀerent patterns of changed
amino acids (Figure 3). When the folP gene from 797 was
clonedinthepUC19vector,itwasshowntoexpressDHPSin
E. coli by transformation of the knock-out strain C600ΔfolP.
The 797 strain readily grew on 0.1mM sulfamethoxazole,
but the cloned folP gene only allowed growth on 0.02mM
sulfamethoxazole.
No genomic sequence of Ss o b r i n u swas available and
it was initially diﬃcult to get the full folP sequence of the
isolates, which was ﬁnally resolved by designing primers
ﬂanking the folP gene of S. downei with a sequence similar
to that of Ss o b r i n u s .T h ef u l lfolP sequence is presented in
Figure 4. Variants of isolate 7(0) showing diﬀerent response
to sulfamethoxazole had exactly the same sequence for folP
andtheupstreamregion.Thesequenceinterveningthegenes
folE (coding for GTP cyclohydrolase) and folP is almost
100bp longer in S. sobrinus than in S. downei (Figures 4
and 5). The intervening sequence shows no similarity to any
sequence in databases and seems thus to be unique to S.
sobrinus (Figure 5). The folP and folA gene sequences of S.
sobrinustogetherwiththefolP sequencesofdiﬀerentvariants
of S. mutans prepared in this study have been submitted to
the European Nucleotide Archive with accession numbers
HE 599533 to HE 599539.
4. Discussion
Viridans group streptococci resistant to antibiotics have
increasingly been reported over the past decade [4, 5], while
studies on antibiotic resistance of mutans streptococcus
group are few [23, 24]. In the present study, cariogenic
mutans streptococci (Streptococcus mutans and Streptococcus
sobrinus) were isolated from patients attending dental and
HIV/AIDScareclinicsinKampala,Uganda,wherestudieson
drug resistance in the commensal ﬂora are scarce, but with a
reported increased use of antibiotics [7]. The most striking
resultistheverydistinctselectionofSXTresistantbacteriain
the prophylaxis group, while resistances to other antibiotics
were not signiﬁcantly diﬀerent between the two groups.
Recently, Wil´ en et al. [25] reported cotrimoxazole resis-
tance in viridans streptococci from the throat ﬂora and
found a 100% frequency of resistance. However, isolates of
Streptococcus mutans and Streptococcus sobrinus were not
included in that previous study [25]. In the present study,
the low level of resistance (15.5%) found in samples from the
nonprophylaxis group might be explained by the diﬀerent
SXT selective pressure in the diﬀerent environments and that
the cariogenic bacteria produce bioﬁlms [26], a protective
mechanism that renders the bacteria to survive antibiotic
exposure.However,thesigniﬁcantlyhigherlevelofresistance
found in the prophylaxis group (54.7%) shows that selective
forces act on the oral and throat ﬂora. The diﬀerences in
resistancelevelmayinsteadbeexplainedbetterbydiﬀerences
in the way the throat commensal ﬂora develop resistance
to SXT [25]. There may also be other limits in the genetic
transfer among the oral compared to the throat ﬂora.
When the nonmutans viridans streptococci resistance
mechanism to SXT was analysed, it was easily identiﬁed
as due to mutational changes in the target enzymes dihy-
dropteroate synthase (DHPS) and dihydrofolate reductase
(DHFR) as well as genetic transfer between diﬀerent strep-
tococcal species [25]. However, ﬁndings from sequencing
of folP and folA genes from resistant MSG in the present
study (Figures 2–5) do not suggest mutational changes in
the DHFR enzyme, nor any genetic transfer of resistance
determinants from the other viridians group streptococci
to S. mutans or S. sobrinus. The lack of changes in the
folA gene suggests a diﬀerent mechanism of resistance to6 International Journal of Microbiology
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Figure 3: Variations in S. mutans DHPS amino acid sequences.
trimethoprim, probably due to gene ampliﬁcation as has
been noted in S. agalatiae [27]. On the other hand, the
folP gene of Streptococcus mutans 797 showed four point
mutations in comparison with NN2025 (Figure 2)a n do n e
in comparison with UA159. Comparison of the positions of
these mutations with resistance determining mutations in
other organisms (Figure 2) shows that they mainly occur in
less conserved parts of the protein and diﬀer quite substan-
tially in positions compared to previously described resis-
tanceconferringmutations[22,25,28–30].Furthersequenc-
ing of other S. mutans isolates showed much more polymor-
phism (Figure 3) and it is evident that the S. mutans DHPS
can vary quite substantially without any obvious relation in
resistance to sulfamethoxazole. The lack of evidence for hor-
izontal transfer of resistance genes from related streptococci
is quite striking. During isolation of the cariogenic bacteria,
it was very common to ﬁnd other commensal streptococcal
species, for example, S. sanguinis, S. parasanguinis, and S.
salivarius in the same isolate. In a few instances we ampliﬁed
folA and folP genes from these other commensal species
and found the expected resistance conferring mutations
described in the previous study [25]. While the resistance
conferring variants of folA and folP are freely disseminated
among most oral streptococcal strains, there seems to be
some barrier that limits transfer of resistance to the cario-
genic bacteria.
Streptococcus sobrinus is quite diﬀerent from S. mutans
in terms of DNA sequence for the genes we studied, but also
inthiscasethesulfa-trimethoprim resistanceseemsnottobe
linkedtosequencediﬀerencesinfolAandfolP.Thesequences
of these genes show high similarity between S. sobrinus and
S. downei (Figure 5), and in few cases we detected S. downei
sequencesinthesamples.Thestrikingdiﬀerencebetweenthe
two bacteria is the intergenic region between folE and folP
(Figure 4). This may need to be explored further regarding
its relation to expression of folP and hence to resistance.8 International Journal of Microbiology
Figure 4: Full S. sobrinus folP gene with translation. Red section is missing in S. downei.
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Figure 5: Comparison of DHPS amino acid sequences between Streptococcus sobrinus (Sobri) and Streptococcus downei (Downei).
However, during cultivation, we obtained S. sobrinus strains
with varying degrees of sulfa and tp susceptibilities, but no
changes were noted in this region.
Despitetheprotectiveeﬀectofcotrimoxazoleprophylaxis
in HIV/AIDS patients from opportunistic infections and
malaria [9], the present study found the drug to select for
resistanceamongthemutansstreptococcisimilartowhathas
been reported in other commensals like Escherichia coli [8].
Looking at other individual resistances rates, there are only a
few studies that speciﬁcally describe Streptococcus mutans or
S. sobrinus. A study from India [22] showed resistance levels
of 20–30% for tetracycline, amoxicillin, and erythromycin.
In the present study, resistance of mutans streptococci to
tetracycline was 35.7%, which is obviously a worrisome
ﬁnding because of the modest cost and easy availability of
the drug in Uganda.
Resistance to amoxicillin, ceftriaxone, and chloram-
phenicol was found in 1.2%, 32.1%, and 6%, respectively, of
the isolates (Table 2). These resistance levels are similar or
higher than those reported from India [22]. Our observed
resistance may be attributed to selection of resistant organ-
isms in the study area similar to the ﬁnding in India [22],
given the prevailing high rate of antibiotic use in the two
countries [7].International Journal of Microbiology 9
Coresistance (resistance to more than one antibiotic)
or the event where microbes acquire resistance to multiple
antibiotics in tandem is extremely troublesome and has
previously been noted [22]. Although we found a slightly
higher prevalence of multidrug resistance in the prophylaxis
as compared to the nonprophylaxis group (Table 3), the
diﬀerence was not statistically signiﬁcant. This could partly
be explained not only by the fact that most of the antibiotics
in the present study are not frequently used in the HIV/AIDS
patients but also by the diﬀerence between the mechanisms
of action of these antibiotics and cotrimoxazole.
Theseﬁndingscallforimprovedsurveillanceofantibiotic
resistance during prophylaxis. Updated information on anti-
biotic resistance such as reported in the present study helps
to inform antibiotic drug policy makers to design strategies
for eﬀective prophylaxis against and treatment of bacterial
infections.
5. Conclusions
In the present study, it has been found that Cotrimoxazole
prophylaxis selects for cognate antibiotic resistance in oral
bacteria. There was a high rate of resistance of Streptococcus
mutans and Streptococcus sobrinus to tetracycline and ceftri-
axone in the studied Ugandan patients independent of SXT
prophylaxis.Genetictransferinthefolatepathwaygenesdoes
not seem to be the mechanism of resistance acquisition.
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